@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/06101097245> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 06101097245" ;
    ns3:publicationDate "2020-03-18"^^xsd:date ;
    dcterms:title "Potential Application Of Endocannabinoid System Agents In Neuropsychiatric And Neurodegenerative DiseasesâFocusing On FAAH/MAGL Inhibitors" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/06101133557>,
        <https://w3id.org/oc/meta/id/062504358230>,
        <https://w3id.org/oc/meta/id/06820241323> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/06104669648>,
        <https://w3id.org/oc/meta/ar/06104669649>,
        <https://w3id.org/oc/meta/ar/06104669650>,
        <https://w3id.org/oc/meta/ar/06104669651>,
        <https://w3id.org/oc/meta/ar/06104669652> ;
    ns4:embodiment <https://w3id.org/oc/meta/re/0610875833> ;
    ns4:partOf <https://w3id.org/oc/meta/br/06101097727> .

